Naperville, IL -- (ReleaseWire) -- 06/02/2014 --Reportstack, provider of premium market research reports announces the addition of Global Cancer Vaccines Pipeline Analysis market report to its offering
Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized. North America has the largest share of the overall vaccines and specifically cancer vaccines market. This is followed by Europe and Asia. North America and Europe are expected to grow at a steady pace in the years to come. However, India and China are expected to see a boost in demand over the next 10 years, owing to their ageing populations and the prevalence of various infectious diseases.

Global Cancer Vaccines Pipeline Analysis by PNS Pharma gives comprehensive insight on the various vaccines being developed for the treatment of multiple cancers. Research report covers all the ongoing vaccines being developed in various development phases. Each vaccine profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each vaccine profile in development phase enables the reader to identify and understand the Cell Therapy associated with the various diseases.

This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the cancer vaccine market based upon development process. Following parameters for each vaccine profile in development phase are covered in Global Cancer Vaccines Pipeline Analysis research report:

Drug Profile Overview

Alternate Names for Drug

Active Indication

Phase of Development

Mechanism of Action

Brand Name

Patent Information

Orphan Designation by Indication, Country & Organisation

Country for Clinical Trial

Owner / Originator/ Licensee/Collaborator

Administrative Route Drug Class

ATC Codes

Breakup of Cancer Vaccines by Development Phase:

Research: 9

Preclinical: 75

Phase-I: 42

Phase-I/II: 32

Phase-II: 43

Phase-II/III: 6

Phase-III: 19

Preregistration: 2

Marketed: 12

To view the table of contents for this market research report please visit
http://www.reportstack.com/product/156588/global-cancer-vaccines-pipeline-analysis.html
Contact:
Roger Campbell
contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
###